Siam Bioscience breaks silence on Thai vaccine deal after Thanathorn criticism

BANGKOK (The Nation/ANN): Siam Bioscience on Monday (Jan 25) released a statement following criticism by Progressive Movement leader Thanathorn Juangroongruangkit over its role in Thailand’s Covid-19 vaccine programme.

Last Monday Thanathorn slammed the government for slowness in providing vaccines, and questioned the transparency of giving a company owned by the Crown Property Bureau – Siam Bioscience – the right to manufacture the AstraZeneca vaccine locally.

Subscribe now for a chance to win your dream holiday!

Monthly Plan


Annual Plan


Billed as RM148.00/year

1 month

Free Trial

For new subscribers only

Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Thailand , Siam Bioscience , Thanathorn , vaccine


Next In Aseanplus News

Asean stands by Myanmar peace plan
Malaysia Fest 2024 Expo in Singapore targets RM20mil in sales, 140,000 visitors
Olympics: India get sleep doctor on board to put performance anxiety to bed
Russia, China FMs meet as Asean talks get underway in Laos
UN agency calls for urgent response to 'alarming' rise in Asia-Pacific bird flu cases
Chinese, Lao foreign ministers vow to expand practical cooperation
China tourist fined S$12,000 for flying drone over Marina Bay on first day of Singapore vacation
Malaysia: All parties must adhere to international law on South China Sea
Actress Fann Wong celebrates husband Christopher Lee’s 53rd birthday with kelong cake
'Back to zero': Manila flood victims clean up, start again

Others Also Read